Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-022289
Filing Date
2017-04-26
Accepted
2017-04-26 16:30:40
Documents
1
Period of Report
2017-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 v465197_form4.html 4  
1 FORM 4 v465197_form4.xml 4 3098
  Complete submission text file 0001144204-17-022289.txt   4470
Mailing Address 2450 SOUTH SHORE BLVD. SUITE 402 LEAGUE CITY TX 77573
Business Address
Foster Jonathan P. (Reporting) CIK: 0001545414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 17784803

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations